Vergelijking

Cetrorelix vs. Linaclotid

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

120287-85-6

851199-59-2

Molecuulmassa

1431.06 g/mol

1526.74 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Cetrorelix

Cetrorelix competitively and immediately blocks the pituitary GnRH receptor, rapidly suppressing LH and FSH release — without the initial hormone surge ('flare') of GnRH agonists.

Linaclotid

Linaclotide activates the guanylate cyclase-C receptor on the luminal surface of the intestinal epithelium. This raises cyclic GMP (cGMP), increases secretion of chloride and bicarbonate into the lumen, raises stool fluid content and accelerates transit; pain signaling is also modulated.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Cetrorelix	Linaclotid
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Cetrorelix

Volledige vermelding →

Linaclotid

Volledige vermelding →

Frequently asked questions

What is the difference between Cetrorelix and Linaclotid?: Cetrorelix is classified as "Onderzoek (overig)", while Linaclotid is classified as "Onderzoek (overig)". Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Cetrorelix or Linaclotid?: The highest available evidence level is "Humane RCT" for Cetrorelix and "Humane RCT" for Linaclotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Cetrorelix and Linaclotid in Germany and the United States?: Duitsland: Cetrorelix — Op recept, Linaclotid — Op recept. Verenigde Staten: Cetrorelix — Op recept, Linaclotid — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Cetrorelix

Linaclotid

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Cetrorelix and Linaclotid?

Cetrorelix is classified as "Onderzoek (overig)", while Linaclotid is classified as "Onderzoek (overig)". Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Cetrorelix or Linaclotid?

The highest available evidence level is "Humane RCT" for Cetrorelix and "Humane RCT" for Linaclotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Cetrorelix and Linaclotid in Germany and the United States?

Duitsland: Cetrorelix — Op recept, Linaclotid — Op recept. Verenigde Staten: Cetrorelix — Op recept, Linaclotid — Op recept. These are factual summaries with source and review date on the individual pages.